UNSPSC 51332504: Benperidol

This classification denotes a dopamine antagonist with the molecular formula C22H24FN3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 97O6X78C53, chemically known as 2h-benzimidazol-2-one, 1-(1-(4-(4-fluorophenyl)-4-oxobutyl)-4-piperidinyl)-1,3-dihydro- but generally known as benperidol, which bears US NIH Compound Identifier 16363. Benperidol most often comes in base and hydrochloride forms. European Medicines Agency schedules Benperidol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05727MIG.

UNSPSC 51332504 Benperidol is a Commodity code that in practice covers procurement of naloxone, drug deactivation systems, and related pharmaceutical products for state and local public health and emergency response use. State and local governments buy these products to support community health initiatives, opioid overdose response programs, and harm-reduction services. Issuing bodies include county health departments and public health authorities; the recent activity sample reflects county-level purchasing for community health infrastructure.

Seminole County, Florida posted an IFB on June 30, 2026 (IFB60459723LAS) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding, with quarterly deliveries to the Seminole County Community Health Building and a response deadline of July 26, 2023. The contract carries a two-year initial term with one-year renewal option, requires e-Verify compliance and drug-free workplace certification, and includes standard commercial and professional liability insurance. Vendors must absorb all shipping and delivery costs in their pricing. The opportunity shows minimal geographic breadth in the source; current activity is concentrated in Florida, with no additional state or local opportunities under this code documented in the recent-opportunities block.